Researchers have identified four new genes that act independently as risk factors for multiple sclerosis.
Patients with RRMS who took the pregnancy hormone estriol in combination with their regular medication were able to avoid relapse, a new study reports.
A new PNAS study reveals why men are less likely to develop multiple sclerosis than women. According to researchers, a 'guardian molecule' that is triggered by testosterone appears to have a protective effect in men. When female mice were treated with the molecule, their symptoms of the disease were eliminated.
Researchers have been able to restore limb mobility and partially re-insulate neurons in mouse models of MS with microRNA treatments.
IndCl, a drug that improves myelination and reduces motor disability, appears to improve visual problems associated with multiple sclerosis.
Researchers have successfully created stem cell derived brain cells which can generate oligodendrocytes, neurons and astrocytes.
The human male and female brains have more in common than the media often reports, suggests Julia Gottwald.
Contrary to popular belief, women with multiple sclerosis may not be at higher risk for complications during pregnancy, such as gestational diabetes or still-birth. However, babies of mothers with MS are more likely to be induced or believed by elective C-sections.
Researchers report people with MS might be able to improve their self awareness through task-oriented cognitive rehabilitation.
A new study links obstructive sleep apnea to a breakdown of the blood-brain barrier.
Researchers report they have successfully developed 'mini-brains' made up of the many neurons and cells in the human brain. The mini brains could allow for better research and reduce the need for animal testing.
A newly developed cannabidiol capsule can be absorbed by the body faster and penetrate the brain more quickly in mouse models of neurological disorders such as Alzheimer's disease, multiple sclerosis and TBI.
